ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced ...
Insulet has begun shipping Omnipod 5 pods with the new algorithm to US retailers ahead of a broader software update.
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today made ...
Insulet Corp.’s PODD recent FDA approval of Omnipod 5 for type 2 diabetes patients is set to expand the product’s market potential. The planned launch of Omnipod 5 with Abbott’s Freestyle Libre 2 Plus ...
Insulet Corporation PODD is driving share gains with its prime Omnipod 5 AID (automated insulin delivery) system, which is highly promising for growth in the upcoming quarters. The company continues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results